• October 27, 2026
Alberta Becomes First Province to Authorize Optometrists for Laser Procedures and Minor Surgical Procedures

The Government of Alberta has announced changes to modernize the scope of practice for optometrists.…

  • October 24, 2026
mEYEspa Launches New Guide on Recurring Red Eyes for Canadian Patients

Canadian eye care retailer mEYEspa has released a patient guide on recurring red eyes, developed…

  • October 23, 2026
Canada’s Eye Care Professionals Warn of Cosmetic Contact Lens Risks Ahead of Halloween

As Canadians prepare for Halloween, the Canadian Ophthalmological Society (COS), the Canadian Association of Optometrists…

  • October 20, 2026
Eye Care Organizations Urge Entire Sector to Sign Global Compact to End Avoidable Vision Loss

Fourteen leading eye health and development organisations called on partners across the eye care sector…

  • October 20, 2026
Prevent Blindness Declares 6th Annual Inflammatory Eye Disease Week

Prevent Blindness has declared its sixth annual Inflammatory Eye Disease (IED) Week as Oct. 19-25,…

  • October 20, 2026
World Council of Optometry and Alcon Dry Eye Web Tools Now Available in 10 Languages

The World Council of Optometry (WCO) and Alcon dry eye initiative’s free digital learning tools…

  • October 20, 2026
RadiusXR and Topcon Healthcare Introduce InspirePRO: The New Standard in Visual Field Testing

RadiusXR and its strategic partner Topcon Healthcare, Inc. introduced InspirePRO at the American Academy of Ophthalmology annual…

  • October 15, 2026
Heidelberg Engineering and RetinAI Expand Ophthalmology Offering with Selected RetinAI Discovery for Clinics Solutions

Heidelberg Engineering and RetinAI (Ikerian AG) announced that they will make RetinAI Discovery for Clinics…

  • October 13, 2026
Optometry Giving Sight Awards Nearly $1 Million in Grants to 20 Organizations Worldwide

Optometry Giving Sight (OGS) is proud to announce the recipients of its 2026 grant cycle,…

  • October 12, 2026
Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting

Bausch + Lomb Corporation announced progress in the development of BL1243 (tonabersat), an investigational oral…